Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression

Transplantation

Volumn 70, Issue 3, 2000, Pages 522-525

  Hoffmeyer, F ^a   Hoeper, M M ^a   Spiekerkotter E ^a   Harringer, W ^a   Haverich, A ^a   Fabel, H ^a   Niedermeyer, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DRUG POTENCY; DRUG WITHDRAWAL; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; LUNG FUNCTION; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL;

EID: 0034663993     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008150-00021     Document Type: Article

References (22)

1. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
2. Risk factors for obliterative bronchiolitis in heart- lung transplant recipients
3. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation - Early risk factors
4. Modern immunosuppression strategies in lung transplantation
5. Incidence and treatment of neoplasia after transplantation
6. Prevalence of malignancies after lung transplantation
7. Collaborative United Kingdom - Australian study of cancer in patients treated with immunsuppressive drugs
8. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone
9. Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: A positive therapeutic aim
10. Effects of azathioprine withdrawal in kidney recipients with stable function two years after transplant
11. Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients
12. Maintenance therapy with triple versus double immunosuppressive regimen in renal transplantation: A meta-analysis
13. A working formulation for the standardization of nonmenclature and for clinical staging of chronic dysfunction in lung allografts
14. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation
15. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation
16. FK506 rescue therapy in lung transplantation
17. Longterm effects of methotrexate in bronchiolitis obliterans following lung and heart-lung transplantation
18. Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation
19. Obliterative bronchiolitis after lung and heart-lung transplantation
20. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation
21. Immunopathological changes in the airways of stable lung transplant recipients
22. Azathioprine: State of the art in inflammatory bowel disease